Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial Article Early Access

cited authors

  • Pandey, Ambarish; Kolkailah, Ahmed A.; Mcguire, Darren K.; Frederich, Robert C.; Cater, Nilo B.; Cosentino, Francesco; Pratley, Richard E.; Dagogo-Jack, Samuel; Cherney, David Z. I.; Wynant, Willy; Gantz, Ira; Mancuso, James P.; Masiukiewicz, Urszula; Cannon, Christopher P.

Publication Date

  • January 10, 2025

webpage

published in

category

keywords

  • Adjudication
  • Ertugliflozin
  • Heart failure
  • Sodium-glucose cotransporter 2 inhibitors
  • Type 2 diabetes mellitus